Nevada Tech Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Nevada Tech Journal.

Press releases published on August 6, 2026

Aug. 6, 2026

Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing

Indeterminate GlobeNewswire

Aug. 6, 2026

Iovance Biotherapeutics Reports Record Second Quarter 2026 Revenue of ~$99M, Business Achievements, and Corporate Updates

Indeterminate GlobeNewswire

Aug. 6, 2026

Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals and Advance Eye Care Leadership Position

Indeterminate GlobeNewswire

Aug. 6, 2026

Immunocore reports second quarter financial results and provides a business update

Indeterminate GlobeNewswire

Aug. 6, 2026

Power Apps Project Stalled or Abandoned: What Actually Fixes It

Indeterminate GlobeNewswire

Aug. 6, 2026

Priovant Announces First Patients Enrolled in Phase 3 Study (BEACON+) of Brepocitinib in Cutaneous Sarcoidosis (CS)

Indeterminate GlobeNewswire

Aug. 6, 2026

Foghorn Therapeutics Provides Second Quarter 2026 Financial and Corporate Update

Indeterminate GlobeNewswire

Aug. 6, 2026

SEO Migration Risk: 4,000 AI Answers Tie 20-40% Traffic Loss to Execution

Indeterminate GlobeNewswire

Aug. 6, 2026

Opus Genetics Announces Financial Results for Second Quarter 2026 and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 6, 2026

Sionna Therapeutics Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 6, 2026

Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 6, 2026

Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 6, 2026

Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates

Indeterminate GlobeNewswire

Aug. 6, 2026

Harrow Acquires Global Rights to TYRVAYA®, the First and Only FDA-Approved Nasal Spray for Dry Eye Disease

Indeterminate GlobeNewswire

Aug. 6, 2026

Intellia Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

Aug. 6, 2026

illumin Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 6, 2026

Verano Announces Upcoming Conference Participation

Indeterminate GlobeNewswire

Aug. 6, 2026

CareCloud Reports Second Quarter 2026 Results

Indeterminate GlobeNewswire

Aug. 6, 2026

Commerce Announces Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 6, 2026

GPGI Reports Second Quarter 2026 Results

Indeterminate GlobeNewswire